DAY 2

7:30 am – 8:30 am – On-going REGISTRATION
7:30 am – 8:30 am – MEET & GREET NETWORKING BREAKFAST
8:30 am – 4:00 pm – 3 Track Sessions:  Clinical Supply Chain, Transportation & Logistics, & Digital Transformation
4:10 pm – 6:00 pm COCKTAIL RECEPTION & AWARDS CEREMONY

AVOIDING CLINICAL SUPPLY CHAIN MISTAKES YOU ARE ABOUT TO MAKE

REGISTRATION & MEET/GREET BREAKFAST

Join Luke Moyer, Head of Global Clinical Supply Chain at Incyte, as he leads a fun and interactive workshop targeted to BSMA attendees who are new to the Clinical Supply Chain Role, as well as experienced clinical supply chain professionals seeking to learn and share best practices.  Working in clinical supply chain can be intimidating to say the least.    It’s an urgent and stressful job with many moving pieces and very few clear answers.  Since Luke’s first clinical supply chain job 25 years ago, he’s learned a lot about what works and what doesn’t, and continues to remind us that “every day you work in clinical supplies is a school day.”  This workshop is designed to accelerate the learning process for novice supply chain managers, and help sharpen the skills of those with experience, helping them to understand key fundamentals and avoid some of the pitfalls many of us learned the “hard way.”

Topics include:

• Your forecast is wrong, and that’s okay

• Building a simple but powerful forecast in Excel

• The difference between overage and safety stock

• Stability protocols and supply planning

• Preventing waste and rework using pull vs. push

• IRT set-up basics

Luke Moyer, Head, Global Clinical Supply Chain, Incyte

12:30 – 1:45 PM SUMMIT  NETWORK LUNCHEON

1:45 pm – 5:00 pm PLENARY SESSION

Columbus & Drake Ballrooms

1:45 pm – 2:05 pm Welcome Address:  SUPPLY CHAIN EXECUTION SAVES HUMAN LIVES – THE UNIVERSAL OUTCOME OF THE PANDEMIC 

Devendra Mishra, Executive Director, BSMA
PPT-Welcome Address

2:05 pm – 2:30 pm  THE 2021 LIFE SCIENCES SECTOR REPORT OF CALIFORNIA

The report of California’s life sciences sector, which directly employed 313,230 people, attracted $12.5 billion in venture capital (VC) and received $5.0 billion in funding from the NIH, will be highlighted to demonstrate its resilience and show the path forward for the ecosystem.

Mike Guerra, President & CEO, California Life Sciences (CLS)
PPT-Life Sciences Sector Report of CA

2:30 – 3:00 pm  DISRUPTION & SUSTAINABILITY FOR LIFE SCIENCE TRANSFORMATION USING METRICS & SIX SIGMA (LITE) METHODOLOGY

The Life science industry is past the debate of managing disruptions while aligning to a sustainability agenda. Building resilience and corporate responsibility into organizational DNA is a necessary requirement. While such a transformation can be daunting, steps can be executed focusing on quick wins while aligning to an overall strategy. Such steps involve focusing on leading indicators – metrics which influence lagging indicators. These indicators include lead-time, on time in full and supplier diversity. This will be a collaborative session where a Six-Sigma methodology and a metricized approach will be reviewed and improved upon by attendees.

Sudy Bharadwaj, Vice President, Strategic Engagements, SAP

2022-06-22 BSMA Session FINAL

3:00 – 3:30 pm  TRANSFORMING THE TRANSPORTATION NETWORK TO A CONTINUOUS PROCESS: MEETING THE DRACONIAN CHALLENGE!

How can drug manufacturers incorporate technologies, in conjunction with forwarders and carriers, to design or select proper packaging and transportation methods to mitigate adverse environmental impacts? How can forwarders/carriers design their SOPs to ensure compliance with Good Distribution Practices? The solution will cover the transportation process of every shipment at every step, considering truck transport, facility storage, limiting tarmac exposure, and timely delivery. The objective is to ensure that every shipment complies with its lane-based transportation SOPs, which validates routes, timing, and product stability limits based on exposure to environmental effects. This can be achieved economically at scale, minimizing product loss, reduced CAPA/SCARs, accurate measurement of forwarder/carrier performance, and a resilient and dependable supply chain. This is like Good Manufacturing Practices, the standard practice for consumer products.

Rich Kilmer, President & CEO, CargoSense

PPT-Transforming the Transportation Network

3:30 – 4:00 pm  NETWORK BREAK

4:00 – 4:30 pm  HOW To ENSURE THAT CLINICAL SUPPLIES IS A TRUE ENABLER OF FASTER CLINICAL DEVELOPMENT TIMELINES

• With pharma and biotechs’ ambitions to do more with less, the supply chain easily becomes the center of attention in the attempt to supply trials faster, more efficiently, avoiding any stockout and with lower waste
• Learn how cross-departmental decision-making in the clinical trial supply, protocol design, upstream manufacturing saves time, drug, costs and ensures all patients are treated at all times;
• Through case studies, we will illustrate the reasons why the supply chain is one of the key enablers of faster time to market, with a 2-6 months acceleration in a program.

Cyrille Lefevre, Life Science Sr. Expert, N-Side

PPT-To Ensure that Clinical Supplies is a True Enabler of Faster Clinical Development Timelines

4:30 – 5:15 pm A GUIDE FOR US BIOTECH LAUNCH IN EUROPE: TRIALS, TRIBULATIONS & TRIUMPHS!

The session will consist of comprehensive Introductory Insights from an expert to address the challenges, pitfalls and personal experiences, followed by a Panel Discussion. Guidelines will be provided for project organization and cross-functional support requirements to manage the EU launch complexity. Useful suggestions will be shared for the selection of EU service providers (3PL, Warehousing & Transportation) and implementation challenges. The Panel Discussion will focus on the pros & cons of engaging in a EU launch readiness project and building your own EU infrastructure. The importance of the cross-functional collaboration to tackle detailed functional interdependencies will be examined. The wrap up will include the testimony on experience related to EU launch readiness, do and do not do and professional feedback.

PANELISTS:
Alyson Naughton, Head of Supply Chain, ADC Therapeutics
Gaspard Jouandon, Former Director of Supply Chain, Novimmune
Franck Toussaint, Managing Director, Biolog Europe
Linda Bliss, Director, Supply Chain, Sonoma Biotherapeutics.
MODERATOR: Laurent Foetisch, Managing Director, Supply Chain Operations SA

PPT-BSMA Panel EU launch

5:15 – 5:30 pm CONNECTING THOSE WHO CARE TO THOSE WHO CURE

Pharma.Aero was established to foster collaboration across industries of Life Science and Medtech shippers and other industry stakeholders. The presentation will highlight how the two giant industries of Life Sciences and Airfreight create supply chains to transport medicine and healing across the planet.

Frank Van Gelder, Secretary General, PHARMA.AERO

PPT-Pharma.Aero – Connecting Those Who Care to Those Who Cure

5:45 pm PROCEED to LOBBY at 5:30 pm for BUSSES to NETWORKING CELEBRATION AT PINSTRIPES (6:00 – 10:00 pm)

6:00 pm – 10:00 pm SOCIAL NETWORKING PARTY

Fun time while networking: food,  wine and beer tasting, games, bocce, bowling, live music

TRACK 3

   DIGITAL  

Chairman:  

Randy Bradley

EVP Digital Transforma-tion in Life Sciences

7:30 am – On-going REGISTRATION

7:30 – 8:30 am MEET AND GREET BREAKFAST

8:30 am – 3:45 pm TRACK 1: SCM INNOVATIONS FROM CLINICAL TRIALS TO COMMERCIALIZATION

Columbus Ballroom

Chairman:  Bill Coakley, Executive Vice President of Clinical & Commercial Supply Chain Mgmt

8:30 – 9:15 am  TOOLS & TECHNOLOGIES BEYOND EXCEL: A SYSTEM EVOLUTION FOR ERP READINESS

Tools & technologies for supporting the planning, manufacturing, storage and distribution of drug product and materials often lag behind in its ability to support successful commercial launches. Many Life Science companies rely on Excel, information from service providers and non-integrated solutions for making critical supply chain decisions. What is the journey companies should make to advance their capabilities from Excel to a full-blown ERP solution? When should these changes occur? How can they obtain the necessary support?

PANELISTS:
Rutesh Desai, Senior Manager, Supply Chain Systems, Beigene
Luke Moyer, Head, Global Clinical Supply Chain, Incyte
Aparna Seksaria, Director Life Sciences Solutions, SAP
Yogendra Chordia, Co-Founder, Schrocken
Moderator: Aaron Chio, Associate Partner, Clarkston Consulting

9:15 – 9:45 am  CLINICAL SUPPLIES PLANNING: STOCHASTIC AND DETERMINISTIC APPROACHES

Tools and approaches vary for clinical supply planning and each has its benefits.  Hear industry leaders share their experiences and perspectives on the value, pros and cons for each option.

PANELISTS
David Volk, Sr. Director, Clinical Supply Operations, Genentech
Jan Pieter Kappelle, VP Strategy, 4G Clinical
Cyrille Lefevre, Life Science Sr. Expert, N-Side
Marc Trombella, Associate Director, Supply Chain, BioMarin Pharmaceuticals
Moderator: Dan Silva, Partner, Tenthpin

9:45 – 10:15 am ENSURING DRUG ACCOUNTABILITY & RECONCILIATION: A CRITICALLY REWARDING MISSION!

Drug accountability and reconciliation requires tracking and maintaining significant amounts of information across your supply chain network and can be one of the major pain points and obstacles for achieving FDA approval for your drug.  Panelists will share best practices, watchouts, & experiences around the requirements and sources of information when going through this process as well as provide some take home guidance on items to consider.

PANELISTS
Derek Thornton, Sr. Manager, Clinical Systems, Amgen
Brittney Elko, Sr. Director, Supply Chain, Tricida
Kathleen Williams, CT PA Manager, Almac Clinical Technologies
Moderator: Jon Paras, Vice President Strategic Solutions, YPrime

10:15 – 11:00 am  NETWORK BREAK

11:00 – 11:45 am  HOW TO SUCCESSFULLY IMPLEMENT DIRECT-TO-PATIENTS CLINICAL STUDIES

Direct to Patient, Site to Patient & Lessons learned from first hand experience over the past few years including protocol, regulatory and technology considerations.  Including setting realistic expectations and ensuring the best possible patient experience.

Jan Pieter Kappelle, VP Strategy, 4G Clinical
Nicole Gray, Director, Strategic Supply Solutions, Catalent

PPT-Direct to Patient Clinical Studies

11:45 am – 12:30 pm  TRANSITIONING FROM CLINICAL TO COMMERCIAL: ENSURING SUCCESSFUL PRODUCT LAUNCH

The transfer of R&D know how and governmental compliance requirements to commercial operations is a monumental chasm that must be overcome in terms of people, processes, organization structures and technology, in addition to understanding the inherent cultural differences of science and mass production. Exacerbating the challenge is the complexity of the ecosystem comprising of the drug developer, CRO, CMO, Logistics and FDA. The diverse stakeholders will address the challenges of bringing drug discovery to the market for significantly greater efficacy, higher success rate, shorter lead time and lower cost. Considering that there is a superordinate goal of maximizing healthcare, exponentially higher alignment of businesses is practical.

PANELISTS
Karl Lovett, Senior Director, Global Supply Chain, Beigene
Arvind Singh, Executive Director, Supply Chain, SK Pharmateco
Ann McMahon, General Manager, Commercial & Integrated Development Operations, Catalent
Marc Trombella, Associate Director, Supply Chain Planning, BioMarin Pharmaceuticals
Chris Armstrong, President Clinical Trials, Thermo Fisher Scientific
Moderator: Bill Coakley, Executive Vice President, Supply Chain, BSMA

12:30 – 2:00 pm  NETWORK LUNCHEON

2:00 – 3:00 pm  LESSONS LEARNED IN THE PLANNING AND EXECUTION OF CLINICAL STUDIES 

Clinical supply professionals and service providers will address challenges and solutions around forecasting, IRT, distribution, comparators and resupply.

PANELISTS
Ryan Mills – Director, Supply Chain, Denali Therapeutics
Scott Sabalvaro, Associate Director Clinical Supply Chain, Pliant Therapeutics 
Dan Hanson, Global Head of Client Services, Clinical Trial Division, Thermo Fisher Scientific
Malou Berdan – Associate Director, Clinical Supply Chain & Logistics, Beigene
Moderator: Mike Dallmann – Senior Director Supply Chain, Avidity Biosciences

3:00 – 3:45 pm  A NOVEL APPROACH TO IRT VENDOR OVERSIGHT

Ensuring clinical trial inspection readiness is not an easy task for sponsors. The coordination of multiple vendors, systems, and other contributors to a clinical trial execution makes the task more complex and time-consuming. YPrime will facilitate a discussion on concepts and novel ideas related to the vendor oversight process for sponsors.

Facilitators: Jon Paras, Vice President Strategic Solutions, and Carly Newhardt, Associate Portfolio Director, YPrime

PPT-A Novel Approach to IRT Vendor Oversight

4:10 – 4:30 pm  AWARDS CEREMONY

4:30 – 6:00 pm  COCKTAIL RECEPTION

WRAP UP

  8:30 am – 4:00 pm Track 2

HOW DO YOU NAVIGATE THROUGH THE PERFECT STORM FACED BY TRANSPORTATION & LOGISTICS IN HEALTHCARE?

Drake Ballroom

Chairman:  Jeff Tucker, CEO, Tucker Company Worldwide

8:30 – 8:45 am WELCOME ADDRESS: Jeff Tucker, CEO, Tucker Company Worldwide

8:45 – 9:30 am SUPPLY CHAIN RESILIENCY IS AS IMPORTANT TO COMPANIES AS IT IS TO NATIONAL SECURITY 

Noted expert in catastrophe planning and the building of resilient supply chains, Phillip Palin, advises the highest levels of the federal government, from emergency officials to national security and the White House. Mr. Palin will review critical learning from the earliest days of Covid-19, including some near catastrophes in healthcare supply chains, and what life-science companies need to think about today, considering the frequency of black swan events such as Covid, port congestion, strikes, wars, tariffs and more. Normal is managing chaos. Resiliency has become essential to staying in business.  

Philip J. Palin, Principal, Private Practice, Supply Chain Resilience, Catastrophe Preparedness 

PPT-Supply Chain Resiliency

9:30 – 9:55 am  CAN LIVE MONITORING PLATFORMS HELP SOLVE THE RENEWED LOGISTICS CRISIS?

Presentation of SkyCell SECURE will be made which is an interoperable Supply Chain Operating System to manage simulation data with real time data and info across all shipping modalities, for any pharma company, manufacturer’s container/packaging/monitoring and global freight forwarder. SECURE brings all shipments data under one platform to Track & Trace, accelerate product release, automatically detect counterfeit and theft of goods, and significantly increase workflow efficiency. In addition to predicting the risk of delivering sensitive drugs by air, it can also reduce CO2 emissions by almost half.

Axel Hartman, Business Development Director, SkyCell Corporate

PPT-Can Live Monitoring Help Solve The Renewed Logistics Crisis

9:55 – 10:40 am GLOBAL TRACKING AND TEMPERATURE MONITORING IN TRANSPORTATION TODAY 

The Covid vaccine distribution–and the ultra-low temperatures some had to maintain–accelerated the development and adoption of various IOT devices to both track the location and monitor the temperature of product. Hear from experts in both the service provider side and the pharmaceutical manufacturing side where this technology is today, and where it’s going.

Dina Bunn, Vice President, Customer Experience, Pharma & Healthcare, JAS Worldwide
Kunal H. Punjabi, Regional Sector Head, Life Sciences & Chemicals, DHL Global Forwarding
Mike Quinn, Director of Sales, North America, ELPRO Global
Moderator:  Jeff Tucker, CEO, Tucker Company Worldwide 

10:40 – 11:00 am NETWORK BREAK

11:00 – 11:45 am SUCCESSFULLY NAVIGATING THE LONGEST AND HIGHEST DEMAND FOR TRUCKING IN HISTORY 

For nearly two years since Spring 2020, demand for trucking has set new historical records. The strain of the post-Covid increase in consumer spending combined with unprecedented shifts in supply chains, with entire industries such as hospitality and restaurant chains temporarily upended, continue to present profound problems for shippers trying to obtain regular, reliable freight transportation. Ports and rail terminals are backed up. Air freight is at record demand. All segments require trucking. Truck drivers are entering business for themselves in record numbers too, skewing the number of drivers toward the smaller size carrier. Hear from industry experts how to secure reliable capacity in cold chain trucking.  

Jeff Tucker, CEO, Tucker Company Worldwide 
Andrew Boyle, Co-President, Boyle Transportation

PPT-Successfully Navigating the Longest & Highest demand for Trucking in History

11:45 am – 12:00 pm SERVICE SHOWCASE – UNITED CARGO

The Post-Covid Airfreight Market – Airliner’s View

Jennifer Haigh, Managing Director Specialty Products, United Cargo – United Airlines

PPT-United Cargo Service Showcase

12:00 – 12:45 pm ENVIRONMENTAL SUSTAINABILITY IN GLOBAL TRANSPORATION 

According to research at MIT, including ports and warehouses, global freight transportation accounts for 11% of all greenhouse gas emissions. And while sustainability may have taken a back seat to supply chain chaos since mid 2020, many companies in both manufacturing and in transportation are taking deliberate and important steps along the pathway to neutral carbon in a few short years. Hear from these companies on what they’re doing, and how each of us might learn, or join in the movement.  

Kunal H. Punjabi, Regional Sector Head, Life Sciences & Chemicals, DHL Global Forwarding
Jennifer L. Haigh, Head of Specialty Products – Americas, United Cargo
Bob Gahan, V.P. & Head of Healthcare,  Kuehne + Nagel North America
Moderator:  Jeff Tucker, CEO, Tucker Company Worldwide

12:45 – 2:00 pm NETWORK LUNCHEON

2:00 – 2:25 pm ECONOMICAL DELIVERY OF COLD CHAIN PRODUCTS: TEMPERATURE PROFILE OF GLOBAL SHIPPING LANES, THERMAL FOOTPRINT OF PAYLOADS & SIMULATION

Disrupted supply chains and extreme weather conditions generate unexpected challenges throughout the world. A three-fold approach of a virtual cold chain to resolve these issues begins with generation of characteristic temperature profiles of a shipping lane worldwide, based on accurate temperature data from thousands of global weather stations. This leads to the determination of the thermal footprint of a passive insulated and temperature-sensitive payload. Finally, simulation yields a lane-independent performance benchmark to compare different pack outs, configurations, and systems on the market for optimization. A case study of distribution lifesaving products from Europe to India will be presented.

Stefan Braun, CEO, SmartCAE

PPT-Economical Delivery of Cold Chain Products

2:25 – 3:10 pm GLOBAL TRANSPORTATION ECONOMIC REVIEW – INCLUDING AIR, OCEAN, TRUCK AND RAIL 

This session will include a comprehensive economic review and update of each mode of transportation. We will detail the state of each mode, and what analysts see as the point at which each may enter a state of relative equilibrium (and if they see that point). If you are involved in any aspect of supply chain and logistics, you will need to hear this. Procurement and logistics managers looking for insights to provide to the C-level and others, this is your session.  

Lee Klaskow, Sector Head and Senior Analyst, Bloomberg

PPT-Global Transporation Economic Review

3:10 – 4:00 pm OH, THE PLACES YOU’LL GO…YOU’LL NEED TEMP CONTROL! TEMP CONROL SHIPPING DEEP DIVE 

The session we’ll go deep and wide into discussion around technology and methods of shipping that keep your product safe and effective throughout its entire journey. It will cover air, ocean, ground, active (powered) temp-control shipping containers, passive (pre-cooled, no-power required) shipping containers, blankets and more. With capacity being as strained as it is, and delays at ports being as long as they are, you might need different techniques. If you’re responsible for temperature-controlled shipping, this is the session you can’t miss. 

PANELISTS
Doug Wettergren, CEO, DoKaSch Americas
Chris Anderson, EVP, Global Sales, Protek Pharma Worldwide
Michael Haley, Business Development Director, SkyCell Americas
Moderator: Jeff Perata, Director, PBO Logistics, Gilead 

4:10 – 4:30 pm  AWARDS CEREMONY

4:300 – 6:00 pm  COCKTAIL RECEPTION

  8:30 am – 4:00 pm TRACK 3: DIGITAL TRANSFORMATION OF HEALTHCARE

Syracuse Room

Chairman:  Randy Bradley, Executive Vice President, Digital Transformation

8:30 – 9:15 am TRANSFORMATION OF SUPPLY CHAINS THROUGH DIGITALIZATION: A PROCESS FIRST APPROACH

Life science organizations are challenged to get traction with the digitalization efforts. Recognizing that organizations of varying sizes are at different stages and have different endpoints in mind, it’s prudent to identify where along the digital journeys organizations win and lose. In this highly interactive session, you gain insights into the three key phases of digital transformation and where organizations get stuck.

Speaker: Dr. Randy V. Bradley, Associate Professor of Information Systems and Supply Chain Management, University of Tennessee

Transformation of Supply Chains Through Digitalization – A Process First Approach_pub_v2

9:15 – 9:45 am DATA-DRIVEN, PROACTIVE MANAGEMENT OF DISRUPTIONS IN THE SUPPLY CHAIN: A GOOGLE CLOUD SOLUTION

From congestion at ports & natural disasters to fluctuating demand patterns, labor shortages, semiconductor shortages, and rising transportation costs, supply chain disruptions are necessitating organizations to leverage technology to enable a more proactive approach to managing their supply chains. This presentation will demonstrate how the Google Cloud is working to address these critical issues to create visibility, flexibility, and intelligence where data serves as the underpinning foundation to make it all happen.

Paula Natoli, Head of Supply Chain & Logistics Industry Solutions – Americas, Google Cloud

9:45 – 10:15 am  THE INDUSTRY 4.0 OPERATING PLATFORM TO TRANSFORM THE END-TO-END SUPPLY CHAIN

The bio-pharmaceutical industry is facing key challenges that are driving supply chain leaders to increase supply chain agility and resilience through digital supply chain transformation. In this session, you learn to vastly improve the way your teams and your supply partner teams work together across pre-clinical, clinical, and commercial stages to transform the way everyday work activities are accelerated through digitalization. Also, learn how a digital network platform can future-proof your supply chain technology infrastructure with multienterprise applications, such as Supply Chain Work Management, that enables step change improvements in cross-company processes.

John Jacey, Director, Digital Supply Chain Solutions, TraceLink 

PPT-The Industry 4.0 Operating Platform to Transform End-to-End Supply Chain  

10:15 – 11:00 am  NETWORK BREAK

11:00 – 11:30 am DIGITAL SUPPLIER NETWORK MAPPING: A TOOL TO ENHANCE RESILIENCE!

Supply chain disruptions in recent years have revealed the vulnerabilities baked into our lean, cost-optimized supply chains. They’ve also highlighted the need for building supply-chain-resilience capabilities to mitigate risk. The presentation will answer fundamental questions of 1. Why supplier network mapping needs to be a top priority?, 2. What makes for a successful mapping model?, and 3. How is technology being deployed to map networks?

Judy Chow, Vice President, Product Management, Resilinc

PPT-Digital Supplier Network Mapping

11:30 am – 12:30 pm  AUTONOMOUS MACHINE LEARNING: THE FUTURE OF ANALYTICS IS HERE

This technology showcase and fireside chat will discuss how companies can and why they should leverage autonomous machine learning (AutoML) to accelerate improved decision-making. Whether you’re still developing your analytics capabilities or have a season-team of data analytics professionals, come learn how AutoML can augment your end-users and by putting the power of advanced analytics in the hands of your “citizen data scientists”.

Arjun Arora, Customer Facing Data Scientist, DataRobot

12:30 – 2:00 pm  NETWORK LUNCHEON

2:00 – 3:00 pm AVOIDING THE PITFALL OF PRIORITIZING TECHNOLOGY OVER PEOPLE IN YOUR DIGITAL STRATEGY

Is digital transformation “much ado about nothing”? There are varying goals associated with a digital strategy. Whereas one might be focused on total transformation others might be simply focused on digitizing data and processes. This panel of industry experts will address challenges they have seen or experienced in relation to their digital initiatives and how others can avoid or mitigate the impact of those challenges. Whether you’re in the early stages of your digital journey or farther down the road, there are still vital lessons to learn about how to ensure you prioritize people and the work over tech. Come be part of the conversation.

PANELISTS:
Leon Trevett, Sr. Director, Global Supply Chain, Illumina
Subhrajyoti (Subbu) Panigrahi, Sr. Director, Gilead
David Volk, Executive Director, Clinical Supply Chain Planning, Genentech
Heather Erickson, Vice President, Supply Chain Management & Business Operations, Sangamo
Matt Donnelly, VP, Global Supply Chain, Biegene
Moderator: Jon Cohen, Head of Life Sciences Industry, GMT, ServiceNow

3:00 – 4:00 pm MOVING a MOLECULE to the MARKET in the CLOUD: The MODERNA REALITY

Understand Moderna’s journey of accelerating COVID-19 vaccine development, scaling systems to enable global distribution, and leveraging cloud technologies to accelerate processes. An extra-ordinary story of the cloud-first and the digital-first company’s fully digitized, paperless, drug design, development, manufacturing execution system and the advanced analytics which sets them apart as the modern technology and the data-driven organization.

Asha D’Souza, Principal Healthcare & Life Sciences Advisor, Amazon Web Services

AWS – Molecule to Market – Digital Transformation

4:10 – 4:30 pm  AWARDS CEREMONY

4:30 – 6:00 pm  COCKTAIL RECEPTION